Results 151 to 160 of about 30,985 (226)

Anti-Human Epidermal Growth Factor Receptor 2 therapies in metastatic colorectal cancer: a systematic review and meta-analysis. [PDF]

Oncologist
Rota S, Di Nardo P, Zottarelli E, Giudici F, Vida R, Zilli M, de Scordilli M, Foltran L, Fumagalli A, Guardascione M, Ongaro E, Puglisi F.   +11 more
europepmc   +1 more source

A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas. [PDF]

Clin Cancer Res
Low JL, Chong WQ, Hui EP, Tan TZ, Lai W, Le TBU, Sooi K, Walsh RJ, Li WY, Kong LR, Lim YC, Chan ATC, Ma B, Goh BC.   +13 more
europepmc   +1 more source

Dynamic coronary roadmap-guided versus traditional percutaneous coronary intervention techniques in contrast medium volume reduction: a systematic review and meta-analysis. [PDF]

Egypt Heart J
Almansi A, Alqato S, Taher LH, Elettreby AM, Batarseh SF, Al-Dardery NM, Otmani Z, Elshenawy S, Abouzid M.   +8 more
europepmc   +1 more source

Targeted therapy plus chemotherapy for advanced or metastatic triple-negative breast cancer: a PRISMA 2020 systematic review and meta-analysis. [PDF]

Front Oncol
Li Y, Li Z, Shi X, Zuo H.
europepmc   +1 more source

Chemoimmunotherapy Combined With Antiangiogenic Therapy in Advanced Triple-Negative Breast Cancer: Real-World Outcomes From a Retrospective Cohort Study. [PDF]

MedComm (2020)
Li Y, Lin J, Zhu M, Cai Z, Jin L, Li S, Shi Q, Lai H, Gong C, Liu Q.   +9 more
europepmc   +1 more source

Facilitating early diagnosis of chronic thromboembolic pulmonary hypertension with dynamic chest radiography: Protocol for a multicenter, assessor-blinded, case-wise randomized superiority reader study (FIND-DCR). [PDF]

PLoS One
Hosokawa K, Yamasaki Y, Kishimoto J, Nagayama T, Adachi S, Naganawa S, Inami T, Yokoyama K, Yasuda S, Takase K, Kubota K, Yoshiura T, Sugiura T, Uno T, Kataoka M, Aoki T, Usui S, Kobayashi S, Taniguchi Y, Murakami T, Tamura Y, Fukumoto Y, Ishigami K, Abe K.   +23 more
europepmc   +1 more source

Efficacy and safety of first-line immune checkpoint inhibitors combinations for extensive-stage small-cell lung cancer: A systematic review and network meta-analysis. [PDF]

Medicine (Baltimore)
Ye X, Meng H, Guo Q, Liang X, Chen X, Li Y.   +5 more
europepmc   +1 more source

Evaluation of the efficacy and safety of first-line therapies for peripheral T-cell lymphoma: a systematic review and network meta-analysis. [PDF]

Front Oncol
Zhao J, Wu B, Jia Y.
europepmc   +1 more source

A Phase II Clinical Trial of Chemotherapy Rechallenge with or without Targeted Therapy in Refractory Metastatic Colorectal Cancer. [PDF]

Oncol Res
Wang C, Huang M, Li W, Sheng X, Zhao X, Zhu X, Chen Z, Zhang Z, Li H, Guo W.   +9 more
europepmc   +1 more source

Streamlining eligibility assessment for Alzheimer's disease-modifying therapies: Prediction of MMSE scores using the digital clock and recall. [PDF]

Front Digit Health
Jannati A, Toro-Serey C, Ciesla M, Chen E, Showalter J, Bates D, Pascual-Leone A, Tobyne S.   +7 more
europepmc   +1 more source